CPB
40
-2
VNO
59
3
MCD
65
2
MO
38
2
SE
61
4
ETR
63
3
PDCO
46
3
PBI
50
4
NTAP
64
3
JNPR
63
3
FLR
66
11
ALLE
71
2
CSCO
67
4
FDX
34
7
TXN
42
2
SBUX
39
3
CRM
59
2
MDLZ
38
2
NRG
65
5
ECL
72
2
CPB
40
-2
VNO
59
3
MCD
65
2
MO
38
2
SE
61
4
ETR
63
3
PDCO
46
3
PBI
50
4
NTAP
64
3
JNPR
63
3
FLR
66
11
ALLE
71
2
CSCO
67
4
FDX
34
7
TXN
42
2
SBUX
39
3
CRM
59
2
MDLZ
38
2
NRG
65
5
ECL
72
2
Financhill
Back

Constellation Software Vs. Kymera Therapeutics Industry Stock Comparison

Buy
66

CSU.TO
Constellation Software

Last Price:
4,431.07
Seasonality Move:
11.07%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Buy
66
Constellation Software (CSU.TO) is a Buy

Is Constellation Software a Buy, Sell or Hold?

  • The current Constellation Software [CSU.TO] share price is $4,409.80. The Score for CSU.TO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • CSU.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CSU.TO Stock Price Chart

What is Constellation Software's stock price today?

  • The Constellation Software share price today is $4,409.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CSU.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

CSU.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 27.85 Buy
Relative Strength Index (14 RSI): 56.36 Buy
Chaikin Money Flow: 14892 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4305.21 - 4404.25) Buy
Bollinger Bands (100): (3912.93 - 4356.89) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

CSU.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4368.48 Buy
20-day SMA: 4368.76 Buy
50-day SMA: 4279.75 Buy
200-day SMA: 3902.32 Buy
8-day EMA: 4381.33 Buy
20-day EMA: 4357.56 Buy
50-day EMA: 4285.43 Buy
200-day EMA: 3882.08 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Constellation Software Earnings Growth & CSU.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.99 per share, a decrease next quarter of $0.00 per share, an increase this year of $20.08 per share, and an increase next year of $25.65 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Constellation Software Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):